Call for Abstract

2nd Euro Oncology Summit, will be organized around the theme “Research Today for a Cancer Free Tomorrow”

Euro Oncology 2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Euro Oncology 2019

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Cancer is one of the leading cause of deaths across the world. Organ Specific Cancers are Cancers named basing on the site of Cancer in the body organ. Its incidence is showing an increasing tendency in various parts of the earth and has been a significant public health problem despite advances in the understanding of the molecular and cellular events that underlie. There are different types of Cancers based on location of cancer in the body organ. For example: Brain Cancer, Head and Neck Cancer, Oral Cancer, Lung Cancer, Liver Cancer, Breast Cancer, Prostate Cancer, Gastric Cancer, Pancreatic Cancer, Kidney (Renal Cell) Cancer, Leukaemia etc. These types of Malignancies come under the category of Organ Specific Cancer.

Radiation Therapy or Radiotherapy is done by using Ionization Radiation to treat Cancer by controlling or destroying malignant cells. Radiation Therapy may be therapeutic in various types of Cancer if they are localized to one area of the body. It can also be used as a part of adjuvant therapy, to prevent tumor recurrence after surgery to remove a Primary Malignant Tumor. Radiation Therapy is synergistic with Chemotherapy, and has been used before, during, and after Chemotherapy in susceptible cancers. The subspecialty of Oncology concerned with Radiotherapy is called radiation Oncology.

Cancer Imaging is the term that covers many approaches used in diagnoses and Research Cancer. It is originally used to diagnose and stage the disease and now it is also used to assist with surgery and Radiotherapy, to identify patients who are responding to treatment and to look for early responses.

Pathology is vital to Cancer diagnosis, treatment and research. Developments in pathology during the 20th century enabled more precise concepts to evolve and be adopted in clinical practice: cancer grading and staging, carcinoma in situ, Cytopathology in screening and diagnosis, immunohistochemistry and biomarkers. As we enter the 21st century, Cancer is acknowledged as a genetic disease that can be diagnosed and treated using molecular/genomic approaches in addition to traditional surgery, radiotherapy and chemotherapy. Another wave of technologic advances in digitization, telepathology, molecular diagnostics and genomic screening marks the latest paradigm shift in Cancer Pathology.

Cancer is basically a disease of tissue growth regulation. In order for a normal cell to transform into a Cancer cell, the genes that regulate cell growth and differentiation must be altered. The affected genes are divided into two broad categories: Oncogenes and Tumor Suppressor Genes. Oncogenes are genes that stimulate cell growth and reproduction. Tumor Suppressor Genes are genes that inhibit cell division and survival. Malignant transformation can occur through the development of novel Oncogenes, the inappropriate over-expression of usual Oncogenes, or by the under-expression or disabling of Tumor Suppressor Genes. Typically, alterations in Multiple Genes are required to transform a normal cell into a Cancer cell.

Cancer Epigenetics deals with the Epigenetic Modifications to the genome of Cancer cells that do not involve any change in the nucleotide sequence. Epigenetic Alterations are as vital as Genetic Mutations in a normal cell transformation to Cancer cells, and their manipulation holds great promise for Cancer prevention, detection, and therapy. In different types of Cancer, a variety of epigenetic mechanisms can be perturbed, such as silencing of Tumor Suppressor Genes and activation of Oncogenes by altered CpG island methylation patterns, histone modifications, and dysregulation of DNA binding proteins. Several medications which have Epigenetic Impact are now used in several of these diseases.

Late logical advancements have helped in understanding the complex connection amongst Microbiome and Cancer. Our body is continuously exposed to Microbial Cells both resident and transient and their byproducts including toxic metabolites. Circulation of toxic metabolites leads to Cancer Progression to distant location from particular microbe resides and may migrate to other locations in the body and associates with Tumor development.

The study of the Genetic Alterations of Tumor Suppressor Genes and Proto-Oncogenes in Solid Tumors has greatly increased our understanding of cancer biology.  Scientists are expanding our understanding of the fundamental processes by which Solid Tumors Develop, progress, and respond to treatment. Efforts span many research areas including cancer genetics and genomics, cell regulation and signalling, cancer metabolism, Tumor Microenvironment, animal models of cancer, and metastasis.

Gene Therapy deals with biomedical research with the objective of impacting the course of different hereditary and procured (alleged multi factorial) diseases at the DNA/RNA level. Cell treatment goes for focusing on different diseases at the cellular level, i.e. by re-establishing a specific cell populace or utilizing cells as therapeutic cargo. For most diseases, gene and cell therapy are applied in combination. Moreover, these two fields have given reagents, ideas, and techniques that are lighting up the better purposes of quality control, stem cell lineage, cell-cell interactions, input circles, enhancement circles, regenerative limit, and redesigning or remodelling.

Cancer Biomarker is a process or a substance that is indicative of the presence of Cancer in the body. A Biomarker may be a molecule secreted by a tumor or specific response of the body to the presence of Cancer. Genetics, epigenetic, glycomic and Imaging Biomarkers can be utilized for the study of Cancer Transmission, conclusion and visualization. Generally such Biomarkers can be assayed in non-invasively collected bio fluids like serum and blood.

Targeted Cancer Therapy is one of the major modes of medical treatment for Cancer. Targeted Therapy blocks the growth of Cancer cells by interfering with Specific Targeted Molecules needed for carcinogenesis and tumor growth rather than by simply interfering with all rapidly dividing cells. Targeted Cancer Therapies are estimated to be more effective than older forms of treatments and less harmful to usual cells. Numerous Targeted Therapies are examples of immunotherapy using immune mechanisms for therapeutic aims developed by the field of cancer immunology. Therefore, as immunomodulators, they are one type of biological response modifiers.

A Cancer Vaccine is a vaccine that helps in treating existing Cancer or prevents its expansion. Vaccines that treat existing Cancer are known as Therapeutic Cancer Vaccines. Some/many of the Vaccines are "autologous", actually prepared from samples taken from the patient, and are specific to that patient. Some researchers claim that cancerous cells usually arise and are destroyed by the immune system and that Tumors form when the immune system fails to destroy them.

Metastasis is the process that permits some Cancer cells to break off from their Tumor of origin and take root in a different tissue. This is the main reason people die from Cancer. Currently, we have unmatched opportunities to unravel the biology of this problem, and a related one – the fact that some Tumors attain resistance to treatments over time. Our investigators pursue each aspect of research into Metastasis and Resistance, including Tumor Microenvironment Interactions, cell regulation, Cancer Stem Cells and more.

Neonatology is a subspecialty of pediatrics that deals with the medical care of newborn infants, especially the premature or ill newborn. It is a hospital-based specialty, and is usually practiced in Neonatal Intensive Care units (NICUs). The chief patients of Neonatologists are newborn infants who are ill or require special medical care due to  intrauterine growth retardation, congenital malformations (birth defects), sepsis, prematurity,  low birth weight, pulmonary hypoplasia or birth asphyxia.

Pediatric Oncology is a branch of medicine deals with diagnosis and treatment of Cancer in Children. Childhood Cancer (also known as pediatric cancer) is Cancer in a child. In the United States, randomly adopted standard of the ages used are 0-14 years is up to 14 years 11.9 months of age. However, the definition of Childhood Cancer includes adolescents between 15-19 years old. Globally it is estimated that Childhood Cancer has an incidence of more than 175,000 per year and a mortality rate of approximately 96,000 per year.

An Oncology Nurse is a specialized nurse who cares for Cancer patients. Cancer patients take a long journey from diagnosis to treatment and beyond. Since cancer affects not only the body but also the psychological and social status of the patient in myriad ways, there is no single path taken by all Cancer patients. The journey is shared between the patient and Healthcare Professionals, and Nurses can provide both care and support to patients throughout their journey.

Palliative Care alludes to treatment that endeavours to enable the patient to feel better and might be joined with an attempt to treat the disease. Palliative Care incorporates activity to decrease physical, enthusiastic, otherworldly and psycho-social trouble.  Unlike treatment that is aimed specifically in destroying Cancer cells. The main objective of Palliative Care is to enhance personal satisfaction.

Complementary and Alternative are the terms that are used to describe many types of products, practices, and systems that are not part of mainstream medicine or standard care. Complementary and Alternative methods privilege to cure Cancer are nearly all unproven methods that are well proven to safely fight Cancer tend to be adopted into mainstream medicine fairly quickly.

Clinical Trials are research studies that involve people. Clinical Trials are the finishing step in a long process that begins with research in a lab. Before any new treatment is used with people in Clinical Trials, researchers work for many years to understand its effects on Cancer cells in the lab and in animals. They also try to figure out the side effects it may cause. Trials are available for all stages of Cancer. It is a myth that they are only for people who have advanced Cancer that is not responding to treatment.

The Discovery and Development of Anticancer Drugs, especially cytotoxic agents, differ significantly from the Drug Development Process for any other indication. The unique challenges and opportunities in working with these agents are reflected in each stage of the Drug Development Process.